ICU sedation, delirium & recovery
Serious Adverse Events in Adult Intensive Care Unit (ICU) Patients: A Substudy of the PATIENCE Cohort
Authors' conclusion
One in four adult ICU patients experienced at least one SAE, with cardiac arrhythmias being the most frequent. Among patients receiving prokinetic agents, the proportion experiencing one or more SAEs ranged from 23.0% to 42.5% across treatment groups. The findings from this study may help inform the design of a future clinical trial.
Study context
- Population
- Acutely admitted adult ICU patients with and without prokinetic treatment (erythromycin, metoclopramide, domperidone, prucalopride)
- Participants
- 1,440 adult ICU patients
- Comparison
- SAE proportions and timing overall and according to prokinetic exposure
- Prokinetic agents for > 3 consecutive daysn = 59
- Not receiving prokinetic agentsn = 1.253
- Primary endpoint
- Proportion of patients experiencing at least one episode of five pre-specified SAEs (cardiac arrhythmias, cardiac arrest, vomiting with aspiration, diarrhoea, extrapyramidal symptoms)
- Follow-up
- During ICU stay
Methodological detailsdescriptive analyses
- Descriptive analyses
Primary result
As reported in the abstract
All patients: patients with serious adverse events (SAEs) (710 SAEs)
354 patients
24.6%
Range across exposure groups, patients with one or more SAEs
23.0% to 42.5%
Secondary outcomes
| Outcome | Prokinetic agents for > 3 consecutive days | Not receiving prokinetic agents |
|---|---|---|
| Any SAE by longest consecutive prokinetic treatment duration | 23.7% | 23.2% |
Cardiac arrhythmias (most common SAE) · during ICU stay
- Patients with cardiac arrhythmias
- 199/1440, 13.8%
Any SAE by longest consecutive prokinetic treatment duration
- Proportion similar
Time to first SAE
Median Day
- After ICU admission
- 2
- After prokinetic initiation
- 3
Original publication
Composed by AI from the published abstract and checked against it. How Briefs are made →